Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047983 · ClinicalTrials.gov registry record · Early Phase 1
Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients
A Early Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
NCT00047983: Completed Early Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00047983 is a Early Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 75 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00047983, a Early Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this study is to develop low risk therapies that will allow improved and lasting survival of donor tissue with minimal suppression of the immune system.
Interventions
- DIETARY_SUPPLEMENT Arginine
- DIETARY_SUPPLEMENT Canola oil
- DIETARY_SUPPLEMENT Fish oil emulsion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Est. Completion | 2004-04 |
| Phase | Early Phase 1 |
What the finished NCT00047983 record still lists
NCT00047983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 3 interventions - of which Arginine is the first listed.
NCT00047983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00047983 about?
NCT00047983 is a clinical study titled "Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients". The purpose of this study is to evaluate the effectiveness of nutritional supplements in increasing the amount of omega-3 fatty acids (and arginine) in the red blood cell membranes and plasma of kidney transplant patients, and, secondarily, to compare patient compliance. The long-term goal of this s...
What is the current status of trial NCT00047983?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 75 participants. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00047983?
The interventions under investigation include: Arginine (DIETARY_SUPPLEMENT), Canola oil (DIETARY_SUPPLEMENT), Fish oil emulsion (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00047983?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00047983's enrollment target sits among peer trials
75 304th of 2000 higher than 1,690 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors